Corporate News
- Cell MedX Corp. Closes Private Placement Financing March 19, 2024
- Cell MedX Corp. Announces Resignation of Director February 28, 2024
- Cell MedX Corp. Appoints Dr. George Adams as Chairman of the Board February 26, 2024
- Cell MedX Corp. Announces New CEO and Directors and Debt Settlement December 19, 2023
- CELL MEDX CORP. Announces Full Revocation of British Columbia Cease Trade Order November 27, 2023
- Cell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating Officer November 9, 2023
- Cell MedX Amends Loan Agreements, Provides Update on Financing and Regulatory Compliance October 18, 2022
- FDA Submission and Corporate Update September 20, 2022
- Cell MedX Corp. Provides Letter to Shareholders from Mr. Dwayne Yaretz, CEO June 27, 2022
- Cell MedX Corp. Appoints Mr. Dwayne Yaretz as CEO and Director April 27, 2022
Historical Press Releases
This website contains historical and archived press releases for Cell MedX Corp. The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cell MedX Corp and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.